Gut Microbiota of Preterm Infants and Full-term Infants at Early Life
Gut Microbial Succession of Preterm Infants and Full-term Infants at Early Life
1 other identifier
observational
102
1 country
1
Brief Summary
The aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome. The hypothesis of the investigators is that the gut microbiota progression of PT group and FT group is different in diversity and composition. Antibiotics and its usage duration is likely the main factor disturbing the colonization and development of the gut microbiome of PT infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2014
CompletedFirst Submitted
Initial submission to the registry
December 11, 2017
CompletedFirst Posted
Study publicly available on registry
December 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2028
April 17, 2024
April 1, 2024
12.3 years
December 11, 2017
April 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
changes in gut microbiota over time and in relation to antibiotic treatment
Fecal DNA at different time points to measure the gut microbiota of preterm infants and full-term infants to investigate the development of early microbial colonization and the impact of antibiotics on the early life of preterm infants
0-7 years after birth
Eligibility Criteria
About 50 preterm infants and 50 full-term healthy infants
You may qualify if:
- Preterm infants
- gestational age \<37 weeks;
- no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis;
- hospital stay \> 7 days;
You may not qualify if:
- NICU stay less than 7 days
- Necrotizing enterocolitis infant
- Control group:
- Full-term healthy infants;
- gestational age \>37 weeks;
- vaginally born;
- no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of NICU, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
Related Publications (1)
Jia J, Shuai M, Yan W, Tang Q, Wang B, Tang W, Wang P, Zhang T, Yang S, Zhang Y, Liu Q, Fu Y, Cai W, Zheng JS. Conserved Covarying Gut Microbial Network in Preterm Infants and Childhood Growth During the First 5 Years of Life: A Prospective Cohort Study. Am J Clin Nutr. 2023 Sep;118(3):561-571. doi: 10.1016/j.ajcnut.2023.07.019. Epub 2023 Jul 29.
PMID: 37517614DERIVED
Biospecimen
Fecal samples of the recruited infants
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jie Jia, PhD
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2017
First Posted
December 14, 2017
Study Start
July 20, 2014
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 20, 2028
Last Updated
April 17, 2024
Record last verified: 2024-04